Stem Cells 2023 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Conference on Cell & Stem Cell Research" (Stem Cells 2023) August 21-23, 2023 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at stem-cell@magnusconference.com or call + 1 (702) 988 2320.
2nd Edition of International Conference on Cell & Stem Cell Research
August 21-23, 2023 | London, UK
Combating COVID-19 with Stem Cells
The world was astonished when a new coronavirus respiratory disease (COVID-19) caused by the SARS-CoV-2 virus emerged, causing social, economic, and health concerns. Since its discovery, various biomedical professionals from around the world have been mobilizing to find a therapy to contain this pandemic infection. As a result, the latest COVID-19 outbreak emphasizes the critical need for safe and effective treatments, particularly for the most severe patients. For regenerative medicine and cellular therapy, stem cells have always been a hot topic. The importance of stem cells in modern medicine is undeniable, both for their application in basic research and for the potential to produce novel medicines in clinical practice. Because of the need of developing innovative and effective treatments for COVID-19, stem cells have taken a prominent role in the scene. Stem cells produced from the amnion of the human placenta, in particular, should be investigated for the treatment of this type of pulmonary diseases, as well as a wide spectrum of disorders, due to their immunoregulatory, reparative, and regenerative qualities.
- Stem Cell Therapy For COVID-19
- Stem Cell Therapy In COVID-19 Respiratory Distress
- Mesenchymal Stem Cells (MSCs)
Alain chapel
Institute of Radiological Protection and Nuclear Safety, France
P K Prem Ravi Varma
Cancer Research Centre, India
Ahmed G Hegazi
National Research Center, Egypt
Alain chapel
Institute of Radiological Protection and Nuclear Safety, FranceSubmit your abstract Today
Title : The adult stem cells and the cancer stem cells in the context of ovarian cancer
Pushpam Kumar Sinha, Independent Researcher, India
Title : Cell based therapies in articular cartilage repair
Anjali Goyal, NHL Municipal Medical College, India
Title : Comparative study on the effect of adipose-derived stem cells versus alpha-lipoic acid inautologus fat graft survival
Sahar Mohamed Mahdy Omar, Ain Shams University, Egypt
Title : Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis
Asma Alanazi, King Saud Bin Abdulaziz University, Saudi Arabia
Title : Stem cell therapy in radiotherapy from bench to clinical trial evaluating the efficacy of Mesenchymal stromal cell injections for the treatment of chronic pelvic complications induced by radiation therapy
Alain chapel, Institute of Radiological Protection and Nuclear Safety, France
Title : Optimized protocol for generating clinical grade umbilical cord tissue mesenchymal stem cell for cell therapy in various disease
Rekha Kumari, Institute of Liver and Billiary Sciences, India